http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111060689-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-532 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-577 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57442 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-532 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-577 |
| filingDate | 2019-11-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2020-12-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2020-12-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-111060689-B |
| titleOfInvention | Endometrial cancer detection kit |
| abstract | The invention relates to the technical field of endometrial cancer diagnosis and detection reagents, in particular to a kit for detecting the concentrations of galectin-3 and CA 125. The kit comprises a tracer labeled CA125 antibody, a tracer labeled galectin-3 antibody, a CA125 antibody coated plate and a galectin-3 antibody coated plate. The kit provided by the invention has high sensitivity and good stability, and can also be applied to endometrial cancer diagnosis and detection kits for disease monitoring and curative effect evaluation. |
| priorityDate | 2019-11-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 60.